C066-0411 Screening compound: 3-(3-chloro-4-methoxyphenyl)-N-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]-4-oxo-3,4-dihydrophthalazine-1-carboxamide

C066-0411 Screening compound: 3-(3-chloro-4-methoxyphenyl)-N-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]-4-oxo-3,4-dihydrophthalazine-1-carboxamide
C066-0411 Screening compound: 3-(3-chloro-4-methoxyphenyl)-N-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]-4-oxo-3,4-dihydrophthalazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-0411
3-(3-chloro-4-methoxyphenyl)-N-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]-4-oxo-3,4-dihydrophthalazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-0411

Molecular Formula

C24H25ClN4O4 (C24 H25 ClN4 O4)

Compound Name

3-(3-chloro-4-methoxyphenyl)-N-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]-4-oxo-3,4-dihydrophthalazine-1-carboxamide

IUPAC name

3-(3-chloro-4-methoxyphenyl)-N-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]-4-oxo-34-dihydrophthalazine-1-carboxamide

SMILES

CC(CCC1)CN1C(CNC(C(c1c2cccc1)=NN(c(cc1)cc(Cl)c1OC)C2=O)=O)=O

InChI

InChI=1S/C24H25ClN4O4/c1-15-6-5-11-28(14-15)21(30)13-26-23(31)22-17-7-3-4-8-18(17)24(32)29(27-22)16-9-10-20(33-2)19(25)12-16/h3-4,7-10,12,15H,5-6,11,13-14H2,1-2H3,(H,26,31)/t15-/m0/s1

InChI Key

BQEUKFORSGPHEU-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD14714394

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.94

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.018

Distribution Coefficient, logD

3.018

Water Solubility, LogSw

-3.57

Polar Surface Area

74.417

Acid Dissociation Constant (pKa)

11.38

Base Dissociation Constant (pKb)

4.40

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

C066-0411 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C066-0411 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-0411?
Check Price and Availability of C066-0411, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-0411 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-0411
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-0411
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-0411 available by request